Literature DB >> 27004790

Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner.

Kristina Holubova1,2, Lenka Kleteckova1,2, Martina Skurlova1,2, Jan Ricny2, Ales Stuchlik1, Karel Vales3,4.   

Abstract

OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect.
METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus.
RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups.
CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.

Entities:  

Keywords:  Antidepressants; Anxiety; BDNF; Bulbectomy; Cognitive deficit; Ketamine; Rapamycin; mTOR

Mesh:

Substances:

Year:  2016        PMID: 27004790     DOI: 10.1007/s00213-016-4256-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  131 in total

1.  Striatal glutamate release during novelty exposure-induced hyperactivity in olfactory bulbectomized rats.

Authors:  Y J Ho; Y C Chang; T M Liu; M Y Tai; C S Wong; Y F Tsai
Journal:  Neurosci Lett       Date:  2000-06-23       Impact factor: 3.046

2.  Differential projections of the infralimbic and prelimbic cortex in the rat.

Authors:  Robert P Vertes
Journal:  Synapse       Date:  2004-01       Impact factor: 2.562

3.  Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.

Authors:  Ying Xu; Bao-Shan Ku; Hai-Yan Yao; Yan-Hua Lin; Xing Ma; Yong-He Zhang; Xue-Jun Li
Journal:  Pharmacol Biochem Behav       Date:  2005-09       Impact factor: 3.533

Review 4.  The role of BDNF in depression on the basis of its location in the neural circuitry.

Authors:  Hui Yu; Zhe-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

Review 5.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

6.  Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.

Authors:  Peter T Tsai; Emily Greene-Colozzi; June Goto; Stefanie Anderl; David J Kwiatkowski; Mustafa Sahin
Journal:  Behav Genet       Date:  2012-12-12       Impact factor: 2.805

7.  Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus.

Authors:  M Roceri; W Hendriks; G Racagni; B A Ellenbroek; M A Riva
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

8.  Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.

Authors:  N V Bobkova; N I Medvinskaya; A V Kamynina; I Y Aleksandrova; I V Nesterova; A N Samokhin; D O Koroev; M P Filatova; P V Nekrasov; A Y Abramov; S V Leonov; O M Volpina
Journal:  Neurobiol Learn Mem       Date:  2013-11-12       Impact factor: 2.877

9.  Regulation of anxiety by GABAA receptors in the rat amygdala.

Authors:  S K Sanders; A Shekhar
Journal:  Pharmacol Biochem Behav       Date:  1995-12       Impact factor: 3.533

Review 10.  Clinical experience with excitatory amino acid antagonist drugs.

Authors:  K W Muir; K R Lees
Journal:  Stroke       Date:  1995-03       Impact factor: 7.914

View more
  8 in total

1.  Ketamine induces immediate and delayed alterations of OCD-like behavior.

Authors:  Summer L Thompson; Amanda C Welch; Julia Iourinets; Stephanie C Dulawa
Journal:  Psychopharmacology (Berl)       Date:  2020-01-11       Impact factor: 4.530

Review 2.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

Review 3.  Mechanisms of ketamine action as an antidepressant.

Authors:  P Zanos; T D Gould
Journal:  Mol Psychiatry       Date:  2018-03-13       Impact factor: 15.992

4.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

Review 5.  Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain.

Authors:  Chulmin Cho; Vassilia Michailidis; Loren J Martin
Journal:  Neurobiol Pain       Date:  2018-03-21

6.  Hippocampus Metabolic Disturbance and Autophagy Deficiency in Olfactory Bulbectomized Rats and the Modulatory Effect of Fluoxetine.

Authors:  Yunfeng Zhou; Xue Tao; Zhi Wang; Li Feng; Lisha Wang; Xinmin Liu; Ruile Pan; Yonghong Liao; Qi Chang
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

7.  Guanosine fast onset antidepressant-like effects in the olfactory bulbectomy mice model.

Authors:  Roberto Farina de Almeida; Camila Barbosa Pocharski; Ana Lúcia S Rodrigues; Elaine Elisabetsky; Diogo O Souza
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

8.  Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway.

Authors:  Anderson Camargo; Ana Paula Dalmagro; Daiane B Fraga; Julia M Rosa; Ana Lúcia B Zeni; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Psychopharmacology (Berl)       Date:  2021-08-03       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.